Branded glatiramer acetate (Copaxone) was approved by the FDA in 1995 at a dose of 20 mg per day, injected […]
This combination seems too good to be true. Fifty-seven patients with episodic migraine, meaning 14 or less attacks per month, […]
Saying “persons with MS” seems clumsy, but when MS patients are asked what they want to be called, they often […]
Progressive multifocal leukoencephalopathy (PML) is the most feared serious adverse effect of use of Tysabri for relapsing MS. The medication […]
They may, but only if combined with cognitive and physical training. This is the conclusion of a 3-year study from […]
Some parents believe that vaccinating their children puts them at risk for numerous disorders, including autism. A new study adds […]
